Pharmacopsychiatry

Papers
(The H4-Index of Pharmacopsychiatry is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels96
Review and Consensus on Pharmacogenomic Testing in Psychiatry88
The History of Psychedelics in Psychiatry50
Psychedelics and Psychotherapy33
Classic Psychedelic Drugs: Update on Biological Mechanisms30
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders30
Cross-Cultural Validity of Psychological Distress Measurement During the Coronavirus Pandemic29
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports26
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review23
Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports18
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study16
Patients’ Perspectives on Psychiatric Pharmacogenetic Testing16
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States14
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease14
0.016555070877075